Coherence principles in dose-finding studies
From MaRDI portal
Publication:3545408
DOI10.1093/BIOMET/92.4.863zbMATH Open1151.62353OpenAlexW2148829424MaRDI QIDQ3545408FDOQ3545408
Authors: Ying Kuen Cheung 
Publication date: 10 December 2008
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/92.4.863
Recommendations
- Cumulative cohort design for dose-finding
- Design efficiency in dose finding studies
- Optimal designs for dose-finding studies
- Efficiency of bridging between related dose finding studies
- Performance Measures in Dose‐Finding Experiments
- Dose-Finding Based on Efficacy-Toxicity Trade-Offs
- A Note on Multiple Testing Procedures in Dose Finding
Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Cited In (19)
- Bayesian models and decision algorithms for complex early phase clinical trials
- Approximate dynamic programming and its applications to the design of Phase I cancer trials
- Statistical frameworks for oncology dose-finding designs with late-onset toxicities: a review
- Incorporating individual and collective ethics into phase I cancer trial designs
- Title not available (Why is that?)
- Optimal designs for dose-escalation trials and individual allocations in cohorts
- Continual reassessment method for partial ordering
- Continual reassessment method with multiple toxicity constraints
- Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
- Cumulative cohort design for dose-finding
- Dose finding with escalation with overdose control (EWOC) in cancer clinical trials
- Semiparametric Dose Finding Methods for Partially Ordered Drug Combinations
- Adaptive clinical trial designs for phase I cancer studies
- Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials
- Efficiency of bridging between related dose finding studies
- Continual reassessment and related dose-finding designs
- Stochastic approximation and modern model-based designs for dose-finding clinical trials
- Simple benchmark for complex dose finding studies
This page was built for publication: Coherence principles in dose-finding studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3545408)
